BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12218381)

  • 1. Evaluation of high-dose estrogen and high-dose estrogen plus methyltestosterone treatment on cognitive task performance in postmenopausal women.
    Wisniewski AB; Nguyen TT; Dobs AS
    Horm Res; 2002; 58(3):150-5. PubMed ID: 12218381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
    Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of methyl testosterone administration on plasma viscosity in postmenopausal women.
    Basaria S; Nguyen T; Rosenson RS; Dobs AS
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):209-14. PubMed ID: 12153599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses.
    Sarrel P; Dobay B; Wiita B
    J Reprod Med; 1998 Oct; 43(10):847-56. PubMed ID: 9800666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire.
    Lobo RA; Rosen RC; Yang HM; Block B; Van Der Hoop RG
    Fertil Steril; 2003 Jun; 79(6):1341-52. PubMed ID: 12798881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone addition to estrogen therapy - effects on inflammatory markers for cardiovascular disease.
    Kocoska-Maras L; Hirschberg AL; Byström B; Schoultz BV; Rådestad AF
    Gynecol Endocrinol; 2009 Dec; 25(12):823-7. PubMed ID: 19906002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women.
    Dobs AS; Nguyen T; Pace C; Roberts CP
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1509-16. PubMed ID: 11932273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen replacement therapy and cognitive functions in healthy postmenopausal women: a randomized trial.
    Gorenstein C; Rennó J; Vieira Filho AH; Gianfaldoni A; Gonçalves MA; Halbe HW; Fernandes CE; Demétrio FN
    Arch Womens Ment Health; 2011 Oct; 14(5):367-73. PubMed ID: 21732218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of esterified estrogens with and without methyltestosterone: effects on endometrial histology and serum lipoproteins in postmenopausal women.
    Hickok LR; Toomey C; Speroff L
    Obstet Gynecol; 1993 Dec; 82(6):919-24. PubMed ID: 8233265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females.
    Duka T; Tasker R; McGowan JF
    Psychopharmacology (Berl); 2000 Apr; 149(2):129-39. PubMed ID: 10805607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive function in association with sex hormones in postmenopausal women.
    Kocoska-Maras L; Rådestad AF; Carlström K; Bäckström T; von Schoultz B; Hirschberg AL
    Gynecol Endocrinol; 2013 Jan; 29(1):59-62. PubMed ID: 22967437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilator effects of estrogen are not diminished by androgen in postmenopausal women.
    Sarrel PM; Wiita B
    Fertil Steril; 1997 Dec; 68(6):1125-7. PubMed ID: 9418709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 3-day estrogen treatment improves prefrontal cortex-dependent cognitive function in postmenopausal women.
    Krug R; Born J; Rasch B
    Psychoneuroendocrinology; 2006 Sep; 31(8):965-75. PubMed ID: 16831520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of low-dose esterified estrogens and methyltestosterone, alone or combined, for the treatment of hot flashes in menopausal women: a randomized, double-blind, placebo-controlled study.
    Liu J; Allgood A; Derogatis LR; Swanson S; O'Mahony M; Nedoss B; Soper H; Zbella E; Prokofieva SV; Zipfel L; Guo CY
    Fertil Steril; 2011 Jan; 95(1):366-8. PubMed ID: 20850731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study.
    Leão LM; Duarte MP; Silva DM; Bahia PR; Coeli CM; de Farias ML
    Eur J Endocrinol; 2006 Jan; 154(1):131-9. PubMed ID: 16382002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver function in postmenopausal women on estrogen-androgen hormone replacement therapy: a meta-analysis of eight clinical trials.
    Gitlin N; Korner P; Yang HM
    Menopause; 1999; 6(3):216-24. PubMed ID: 10486791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of a testosterone gel in healthy postmenopausal women.
    Singh AB; Lee ML; Sinha-Hikim I; Kushnir M; Meikle W; Rockwood A; Afework S; Bhasin S
    J Clin Endocrinol Metab; 2006 Jan; 91(1):136-44. PubMed ID: 16263817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being.
    Flöter A; Nathorst-Böös J; Carlström K; von Schoultz B
    Climacteric; 2002 Dec; 5(4):357-65. PubMed ID: 12626215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women.
    Chiuve SE; Martin LA; Campos H; Sacks FM
    J Clin Endocrinol Metab; 2004 May; 89(5):2207-13. PubMed ID: 15126543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.